Eventide Asset Management - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 40 filers reported holding DICE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$20,778,000
-41.0%
1,370,261
-26.8%
0.44%
-19.6%
Q1 2022$35,202,000
-23.1%
1,871,6120.0%0.55%
-5.6%
Q4 2021$45,761,000
-22.7%
1,871,6120.0%0.58%
-25.1%
Q3 2021$59,213,0001,871,6120.78%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$62,993,00033.95%
Sands Capital Ventures, LLC 3,148,970$60,240,00012.58%
OUP Management Co., LLC 536,693$10,267,0007.82%
New Leaf Venture Partners, L.L.C. 556,693$10,650,0005.25%
Logos Global Management LP 1,385,251$26,500,0003.44%
Soleus Capital Management, L.P. 983,994$18,824,0002.43%
RA Capital Management 5,208,911$99,646,0002.17%
Deep Track Capital, LP 1,250,000$23,913,0001.53%
Samsara BioCapital, LLC 228,466$4,371,0001.10%
HighVista Strategies LLC 48,960$937,0000.60%
View complete list of DICE THERAPEUTICS INC shareholders